Senior Director, Business Development at evitria AG
Mail: lm@evitria.com
Since 2020, Lisa Meza has worked as Senior Director of Business Developement at evitria. She has profound experience in the biotechnology industry, with professional skills in the fields of antibodies, flow cytometry, life sciences, and Western Blotting.
With a Bachelor of Arts in Anthropology and a Bachelor of Science in Microbiology from the New Mexico State University and an MFS in Forensic Sciences from the National University, Lisa has acquired broad academic knowledge from different fields, along with extensive business experience.
LinkedIn profile: Lisa Meza
Articles
This post will highlight the core activities in the growing market of CROs, how to avoid the potential pitfalls of unreliable CROs, and point out how your organization can benefit from outsourcing to recombinant antibody expression service providers like evitria.
Antibody development and antibody expression have become essential in life-science and the biopharmaceutical industry. In particular, advanced methods of creating and selecting recombinant antibodies have enabled science and medicine alike to progress in unanticipated speed.